Skip to main content
OpenTrials
Completed

NCT Number: NCT04907487

Évaluation de l'Impact du Compressed Sensing Sur le Signal QSM

Patients who have agreed to participate in the study will complete the MRI protocol as part of routine care, to which a maximum of four additional 25-minute sequences will be added.

MRI of routine care includes at least the following sequences:

* 3D T1 TFE (2 minutes) * T2 TSE (2 minutes) * 3D FLAIR (3 minutes)

The sequences added by the research lasting 25 minutes are:

* SWI QSM 1.0iso 8 echoes (10 minutes) * SWI QSM 1.0iso 8 echoes CS 6 (7 minutes) * SWI QSM 1.0iso 8 echoes CS 9 (5 minutes) * SWI QSM 1.0iso 8 echoes CS 12 (3 minutes)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

MRI

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hhopital fondation adolphe de rothschild

Paris, 75019, France

About this study

Patients who have agreed to participate in the study will complete the MRI protocol as part of routine care, to which a maximum of four additional 25-minute sequences will be added.

MRI of routine care includes at least the following sequences:

  • 3D T1 TFE (2 minutes)
  • T2 TSE (2 minutes)
  • 3D FLAIR (3 minutes)

The sequences added by the research lasting 25 minutes are:

  • SWI QSM 1.0iso 8 echoes (10 minutes)
  • SWI QSM 1.0iso 8 echoes CS 6 (7 minutes)
  • SWI QSM 1.0iso 8 echoes CS 9 (5 minutes)
  • SWI QSM 1.0iso 8 echoes CS 12 (3 minutes)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

For patients with MS:

  • Patient over 18 years old
  • Presenting MS defined according to McDonald's revised criteria for spatial and temporal clinical or radiological dissemination [16],
  • Should benefit as part of the care of an MRI examination with or without injection of gadolinium
  • Express consent to participate in the study
  • Affiliate or beneficiary of a social security scheme

For patients with an indication to undergo a brain MRI and at low risk of inflammatory CNS disease:

  • Patient over 18 years old
  • Should benefit as part of the care of an MRI examination with or without injection of gadolinium
  • Express consent to participate in the study
  • Affiliate or beneficiary of a social security scheme

Exclusion criteria

  • For patients with MS:
  • Patient benefiting from a legal protection measure
  • Pregnant or breastfeeding woman

For patients with an indication to undergo a brain MRI and at low risk of inflammatory CNS disease:

  • Patient benefiting from a legal protection measure
  • Pregnant or breastfeeding woman
  • Patient with inflammatory and / or demyelinating pathology of the CNS

Secondary exclusion criteria :

  • Motion artefact not allowing interpretation of images
  • Patient who did not perform one of the following sequences: 3D T1 TFE, 3D FLAIR (for MS patients), SWI QSM 1.0iso 8 echoes.

Secondarily excluded patients will be replaced.

Treatment and study plan

MRI

Device

MRI of routine care includes at least the following sequences:

  • 3D T1 TFE (2 minutes)
  • T2 TSE (2 minutes)
  • 3D FLAIR (3 minutes)

The sequences added by the research lasting 25 minutes are:

  • SWI QSM 1.0iso 8 echoes (10 minutes)
  • SWI QSM 1.0iso 8 echoes CS 6 (7 minutes)
  • SWI QSM 1.0iso 8 echoes CS 9 (5 minutes)
  • SWI QSM 1.0iso 8 echoes CS 12 (3 minutes)

Primary outcomes

  1. concordance of QSM signal with and without compressed-sensing in white matter

    Time frame: 1 DAY

    concordance of QSM signal with and without compressed-sensing in white matter

Sponsors and collaborators

Lead sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Network

Registry information

Acronym: CS-QSM

Important dates

Study start
2021
Primary completion
2025
Study completion
2025
First posted
May 28, 2021
Registry last updated
Jan 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.